| Trial ID: | L4701 |
| Source ID: | NCT05786521
|
| Associated Drug: |
Semaglutide Injectable Product
|
| Title: |
Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
|
| Acronym: |
|
| Status: |
ACTIVE_NOT_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Aging|Diabetes Mellitus, Type 2|PreDiabetes|Overweight and Obesity
|
| Interventions: |
DRUG: Semaglutide Injectable Product|BEHAVIORAL: Lifestyle Counseling
|
| Outcome Measures: |
Primary: Lean body mass change, Determine if there is any change in lean body mass, 20 weeks |
|
| Sponsor/Collaborators: |
Sponsor: The University of Texas Health Science Center at San Antonio | Collaborators: National Institute on Aging (NIA)
|
| Gender: |
ALL
|
| Age: |
OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2023-04-01
|
| Completion Date: |
2025-01-31
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-22
|
| Locations: |
UT Health San Antonio, San Antonio, Texas, 78229, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT05786521
|
